Catherine Stehman-Breen
InvestorVenture Partner at F-Prime Capital · Board director at Generation Bio
Cambridge
Find your path to Catherine
134 people in our graph share verified history with Catherine — schools, employers, funds. One of them is your warm intro.
About
Venture Partner at F-Prime based in the Cambridge office, focused on new company creation, with over 30 years of medical and biopharmaceutical experience. She previously served as CEO of Chroma Medicine, CRDO at Obsidian Therapeutics, EIR at Atlas Venture, and CMO at Sarepta Therapeutics, and holds an MD from the University of Chicago and an MS in epidemiology from the University of Washington.
Invests in
Biotech
Board director at Generation Bio
Intro paths
In turn, Catherine can intro founders to Generation Bio's investors below.
Deals · 1
Generation BioBoard seat
via F-Prime Capital · filed Mar 2018 · $100.4M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at F-Prime Capital
Frequently asked questions
- Who is Catherine Stehman-Breen?
- Venture Partner at F-Prime based in the Cambridge office, focused on new company creation, with over 30 years of medical and biopharmaceutical experience. She previously served as CEO of Chroma Medicine, CRDO at Obsidian Therapeutics, EIR at Atlas Venture, and CMO at Sarepta Therapeutics, and holds an MD from the University of Chicago and an MS in epidemiology from the University of Washington.
- Where does Catherine Stehman-Breen work?
- Catherine Stehman-Breen is Venture Partner at F-Prime Capital and Board director at Generation Bio.
- What does Catherine Stehman-Breen invest in?
- Catherine Stehman-Breen invests in Biotech.
- What boards does Catherine Stehman-Breen sit on?
- Catherine Stehman-Breen holds tracked board seats at Generation Bio.